You searched for "impaired"

1522 results found

In conversation with Richard Baker, Policy Manager for the Royal Blind and Scottish War Blinded

The Eye News team recently met with Richard Baker, Policy Manager for the Royal Blind and Scottish War Blinded, Scotland’s biggest vision impairment third sector organisation. Richard chats about the Eye News Symposium and explains more about the work of...

All you need to know about PIC

This is a review article of punctate inner chorioretinopathy (PIC). The authors detail the epidemiology and clinic presentation of the disease. They recognise the challenge of an accurate diagnosis due to its resemblance to other posterior uveitic entities. Multimodal imaging...

Strategies for managing neovascular AMD and DMO in routine clinical care

Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...

High dose (2.5mg) bevacizumab for postradiation cystoid macular oedema

The authors present a retrospective, interventional case series investigating the efficacy of high dose (2.5mg/0.1ml) intravitreal bevacizumab in the treatment of persistent postradiation (Iodine-125 plaque brachytherapy for uveal melanoma) cystoid macular oedema (CME). Persistent CME was defined as increased or...

Rebamipide 2% for dry eye

Rebamipide is a quinolinone derivative that has been found to increase mucin production and the number of conjunctival goblet cells. A previous phase two study has shown rebamipide 2% to be better than placebo in improving the ocular surface and...

Tips for the Online Proctored FRCOphth - Part 1

The FRCOphth Part 1 examination is a difficult exam in itself, testing candidates on a wide range of theoretical and biomedical ophthalmology. This used to be a two-part pencil-on-paper written examination, which was then digitalised for October 2019 and January...

Evaluation of a service providing sight impairment registration for stroke survivors

This service evaluation study of a hospital single centre stroke service was undertaken to determine reasons for declining sight registration, whether patients feel supported without registration and determine changes needed to improve registration processes. A review of existent data was...

OXSIGHT Onyx – A sight-enhancing wearable

The Onyx is a newly-released (late 2021) wearable with a powered magnifier to assist those with central vision impairment. Unlike the previously covered wearable devices, this enhances existing sight. The unit can either be held against the eyes when needed,...

Minimally Invasive Glaucoma Surgery: What options are there and when might they be considered?

In recent years there has been a rapid expansion in a group of operations termed ‘minimally invasive’ or ‘micro invasive’ glaucoma surgery (MIGS). These options generally offer less significant IOP reduction, but with a more favourable safety profile when compared...

Fight for Sight to maximise impact by funding solutions-focused research in priority eye conditions

Fight for Sight aims to stop sight loss by funding pioneering research. Rod McNeil takes a look at the Primer Fellowship Awards programme, which provides funding for up to £60,000 for individuals to undertake vision-related research for one year. Among...

The friendly face of ophthalmology

The friendly face of ophthalmology

Effect of heredity on risk of diabetic retinopathy

This study used survival analysis on 2199 patients who had reached vision-threatening diabetic retinopathy to investigate the contribution of heredity to diabetes together with other known risk factors for the development of either proliferative diabetic retinopathy (PDR) or diabetic macular...